Risk of cancer development associated with disease-modifying therapies for multiple sclerosis: study protocol for a systematic review and meta-analysis of randomised and non-randomised studies.

Autor: Catalá-López, Ferrán1,2,3 (AUTHOR) ferran_catala@outlook.com, Tejedor-Romero, Laura4 (AUTHOR), Driver, Jane A.5,6,7 (AUTHOR), Hutton, Brian3,8 (AUTHOR), Sánchez-Ortí, Joan Vicent2,9 (AUTHOR), Ridao, Manuel10,11,12 (AUTHOR), Alonso-Arroyo, Adolfo13,14 (AUTHOR), Correa-Ghisays, Patricia2,9 (AUTHOR), Forés-Martos, Jaume2,15 (AUTHOR), Balanzá-Martínez, Vicent2,9 (AUTHOR), Valencia, Alfonso16,17 (AUTHOR), Cobos, Inmaculada15 (AUTHOR), Tabarés-Seisdedos, Rafael2,9 (AUTHOR) rafael.tabares@uv.es
Zdroj: Systematic Reviews. 10/18/2024, Vol. 13 Issue 1, p1-8. 8p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje